Skip to content

CERSI-PGx launches new module: ‘Evaluating Pharmacogenomic Evidence: from GWAS to Regulatory Decisions’

CERSI-PGx has added a tenth module to its growing collection of free pharmacogenomics eLearning, following a two-part module added last month.

About CERSI-PGx

CERSI-PGx is a collaborative group focused on advancing pharmacogenomics (PGx) research, education and its application in practice. Its free eLearning platform, launched in January 2026, provides accessible learning developed with subject specialists and lets researchers, healthcare professionals, and other scientific audiences explore key topics at their own pace. Since launch, the group has released nine modules covering various aspects of pharmacogenomics (PGx), with the tenth module launching today.

New module

The new module – ‘Evaluating Pharmacogenomic Evidence: from GWAS to Regulatory Decisions’ – is available to access now. Developed by Professor Sandosh Padmanabhan, Pontecorvo Chair of Pharmacogenomics at the University of Glasgow, the module explores how pharmacogenomic evidence is evaluated, from genome-wide association studies (GWAS) through to the decisions made by regulators. Users will learn how PGx evidence is evaluated and graded, and how it can inform regulatory decisions and clinical practice. Using a case study taking the role of a regulator reviewing a fictional drug application, learners explore the ClinPGx levels of evidence and scoring system, compare candidate gene studies with genome-wide association studies (GWAS), and examine how GWAS are conducted and interpreted. 

The module is designed for researchers, healthcare professionals, regulators and other scientific audiences who want to build confidence in appraising pharmacogenomic evidence and understanding how it can inform research and practice.

A growing collection of free learning

The new module adds to the growing CERSI-PGx collection of ten modules, including the two-part module on Pharmacogenomics in Practice, launched on 21 October. Learners can work through the content at their own pace, revisit topics when needed and explore the modules most relevant to their interests and professional development.

Modules

Modules currently available are:

  • Intro to PGx - Part A: Concepts and foundations
  • Intro to PGx - Part B: Regulatory applications
  • PGx testing and companion diagnostic: What assessors want to see in applications for regulation
  • Post‑Marketing Surveillance: Evaluating PGx‑related toxicity signals
  • Post‑marketing surveillance: Evaluating PGx‑related efficacy signals
  • Generating and evaluating PGx evidence
  • Pharmacogenomics in Practice Part A: Clopidogrel guidelines – New!
  • Pharmacogenomics in Practice Part B: Clopidogrel case study – New!
  • Evaluating Pharmacogenomic Evidence: from GWAS to Regulatory Decisions – New!

Updated features

If you haven't tried the platform or haven’t logged in recently, now is a great time to check it out! Recent updates include:

  • A streamlined sign-up process
  • Downloadable certificates after completing each module, including retrospectively for modules already completed
  • Glossary/definition functionality
  • Learner feedback functionality

Start learning today

Visit the CERSI-PGx eLearning platform to create your free account and start developing your knowledge of pharmacogenomics.
 


Press releases Clinical pharmacology Pharmacogenomics/Pharmacogenomics Clinical Pharmacology

Latest news & activity

Prizes and awards

The British Pharmacological Society (BPS) recognises recipients of 2026 student awards and prizes.

Press releases

CERSI-PGx is expanding its free pharmacogenomics eLearning offer with the launch of new modules.

Grant

Applications are now open for the BPS Education Grant.

The grant awards up to £2,500 to support the creation or development of educational tools and…